digital health companies weight loss glp-1

digital health companies weight loss glp-1 Miami's eMed just hit a $2 billion valuation—and Tom Brady is now its chief wellness officer. The company raised $200 million in series A funding to advance its AI-powered platform GLP-1 Weight Loss Medication |

Name: digital health companies weight loss glp-1 Miami's eMed just hit a $2 billion valuation—and Tom Brady is now its chief wellness officer. The company raised $200 million in series A funding to advance its AI-powered platform GLP-1 Weight Loss Medication |
Brand: european-airwings.de
SKU: 73069149
Price: 21.23 USD
Availability: InStock
Rating: 4.2718 (18 reviews)

SKU: 73069149

4.3

EUR21.23 EUR61.23

Pay in 4 interest-free payments of $5.31 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial

10.1016/j.ccr.2006.08.015 Cancer Cell 164 SenaL

Research Methodology The researchers used structured secondary data analysis to analyze peer-reviewed studies, experimental datasets, and clinical reports